post-stroke cognitive impairment
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients who meet the diagnosis of stroke and are confirmed by CT or MRI; (2) Both MMSE scale screening and MOCA assessment scale confirmed cognitive impairment; (3) Cognitive impairment occurs after the occurrence of stroke, and other causes are excluded; (4) The course of disease is within one month to one year; no cognition-improving drugs have been used before enrollment; (5) Sober consciousness and stable vital signs; (6) Aged 30 to 75 years; (7) The patient or his/her legal guardian agrees and has signed an informed consent.
Exclusion criteria
Exclusion criteria: (1) There are non-stroke diseases that can cause cognitive impairment, such as annoying space occupying lesions, brain trauma, and arterial hemangioma; (2) Diseases with severely affecting cognitive tests, such as abnormal audiovisual and mental disorders; (3) A history of significant cognitive decline or dementia before the illness; (4) Patients with other serious diseases such as immune diseases, endocrine diseases and abnormal liver and kidney functions; (5) pregnant and lactating women; (6) Other clinical trial participants who are influencing the evaluation of the results of this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Simple intelligent mental state scale;Montreal cognitive assessment scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Daily living ability scale; | — |
Countries
China
Contacts
The First Affiliated Hospital of Henan University of Chinese Medicine